Current Investment Opportunities for PE Investors
15-06-2011
Replicon Corporate Finance is pleased to announce following private equity investment opportunities for relevant Venture Capital funds, Business Angels and Industrial or Commercial Players.
Due to confidentiality reasons Replicon doesn’t publish the names of our clients in this context. We are happy to provide more material on these private equity offerings on request.
| Description | Size of the Financing Round | Stage, Expected EXIT |
|---|---|---|
| Wlan Performance Optimizer | 1.0 - 3.0 M€ | A round, International Expansion, EXIT~3-6 yrs. |
| Unique Wellness Concept | 5 M€ or 10 M€ | Project Financing, Partial Spin Off, EXIT~2-4 yrs. |
| Innovative Healthcare Solution | 0.7 – 2.0 M€ | Growth Financing and a Trade Sale Opportunity, EXIT~4-6 yrs. |
ADDITIONAL NOTES: All of the current offerings are priced in relative terms modestly. Investor groups are also accepted. All investors must have experience in growth financing deals.
Additional information:
Wlan Performance Optimizer: minimum investment size 50 000 euro, indicative investment interest preferably by the end of July, road show meeting on Monday, 27th of June in Helsinki / WTC,
targeted closing of the financing August / September
Unique Wellness Concept: minimum investment size 250 000 euro, indicative interest preferably by 15th of July, meeting with investor(s) agreed separately
targeted closing (LOI) of the financing by the end of August
Innovative Healthcare Solution: minimum investment size 100 000 euro, indicative interest by the end of August, meeting with investor(s) agreed separately but earliest in August,
targeted closing by the end of October, 2011
The above list represents situation in June 2011. It is non-exhaustive and naturally evolves over time.
For further information on above offerings, please contact
Petteri Hirvonen, CEO, Senior Partner
+358 9 677 464 or
+358 50 552 9633 (direct)
This email address is being protected from spambots. You need JavaScript enabled to view it.
Arsi Rosengren, Associate Director, Partner
+358 40 503 3553 (direct)
This email address is being protected from spambots. You need JavaScript enabled to view it.
About Replicon
Replicon Group is an independent financial and business adviser for growth companies and growth investors. We are a Certified Adviser in NasdaqOMX First North market place and a qualified operator in publicly funded growth company programs. Replicon provides financial and related strategic solutions that facilitate business activities, efficiency, and increase profitability of corporations and other organizations. Our core competence is in solutions that facilitate growth based on innovation in ict, healthcare, cleantech and biotech sectors. Replicon’s homepage is www.replicon.fi